CASI Pharmaceuticals Inc (NASDAQ: CASI) stock closed at $6.50 on 10/25/24 after a major increase of 11.5%. However, exceptionally low trading volume at 36% of normal accompanied the advance. Relative to the market the stock has been exceptionally strong over the last nine months and has risen 19.7% during the last week.
Current PriceTarget Research Rating
CASI is expected to be a major Value Builder reflecting capital returns that are forecasted to be above the cost of capital.
CASI Pharmaceuticals has a current Value Trend Rating of C (Low Neutral). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing very contradictory signals. CASI Pharmaceuticals has a very low Appreciation Score of 6 but a very high Power Rating of 92, producing the Low Neutral Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment